Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants

Abstract

RSVpreF vaccine administered during pregnancy was effective against medically attended severe RSV-associated lower respiratory tract illness in infants, and no safety concerns were identified. (Funded by Pfizer; MATISSE ClinicalTrials.gov number, NCT04424316.).